Market Tracker

11/28 6:05pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

18.74
Data as of Nov 28
 +0.17 / +0.92%
Today’s Change
5.40
Today|||52-Week Range
25.60
+153.59%
Year-to-Date
Regulus Therapeutics (RGLS) In A Perilous Reversal
Nov 25 / TheStreet.com
50/50 Basket Update
Nov 08 / StockTwits
Morning Market Movers
Nov 24 / Benzinga
Position Updates
Nov 01 / StockTwits
Position Updates
Nov 15 / StockTwits
 

Today’s Trading

Previous close18.57
Today’s open18.41
Day’s range18.40 - 20.08
Volume903,773
Average volume (3 months)1,547,315
Market cap$902.6M
Dividend yield--
Data as of 1:00pm ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-105.78%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book8.30

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-1.05-2.19%
SGNTSagent Pharmaceutica...+0.01+0.03%
ARNAArena Pharmaceutical...+0.07+1.70%
FWPForward Pharma A/S-0.06-0.30%
Data as of 1:00pm ET, 11/28/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts